Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 601–700 of 1,000
Advancements in nanotheranostics for glioma therapy
Sahoo, L., Paikray, S. K., Tripathy, N. S., Fernandes, D. A., & Dilnawaz, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03559-w · Cited by 13
Tumour heterogeneity and personalized treatment screening based on single-cell transcriptomics
Zhang, X., Xie, J., Yang, Z., Yu, C. K. W., Hu, Y., & Qin, J. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.12.020 · Cited by 14
Lee, H. J., Park, S. W., Lee, J. H., Chang, S. Y., Oh, S. M., Mun, S., Kang, J., Park, J., Choi, J. K., Kim, T. I., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-02964-z · Cited by 14
Liu, T., Xia, F., Zheng, Y., Xiao, H., Yu, Y., Shi, J., Wang, S., Shi, X., He, Z., Sun, J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00810 · Cited by 12
Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment
Gottlieb, B., Trifiro, M. A., & Batist, G. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.10.013 · Cited by 15
Chitosan-based drug delivery systems in cancer therapeutics
Padhi, S., Behera, A., Hasnain, M. S., & Nayak, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819336-5.00011-x · Cited by 17
Circulating miRNA expression over the course of colorectal cancer treatment
Kúdelová, E., Holubeková, V., Grendár, M., Kolková, Z., Samec, M., Váňová, B., Mikolajčík, P., Smolár, M., Kúdela, E., Laca, Ľ., et al. (2021) · Oncology Letters · doi:10.3892/ol.2021.13136 · Cited by 12
Multifarious targets beyond microtubules—role of eribulin in cancer therapy
Seshadri, P., Deb, B., & Kumar, P. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s559 · Cited by 12
Liu, S., Xu, C., Zhang, K., Han, D., Yang, F., Li, Y., Zhao, X., Ma, S., Li, H., Lu, S., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-6271 · Cited by 14
Oncolytic Viruses as Nanomedicines against the Tumor Microenvironment
Zaheer, U., Hassain, N. A., Banu, S., & Mathew, S. (2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac116.1482514852 · Cited by 15
Wang, D., Gu, Y., Huo, C., Zhao, Y., Teng, M., & Li, Y. (2022) · Gene · doi:10.1016/j.gene.2022.146760 · Cited by 13
T-Cell Mediated Immunity in Merkel Cell Carcinoma
Ouyang, K., Zheng, D. X., & Agak, G. W. (2022) · Cancers · doi:10.3390/cancers14246058 · Cited by 12
Malgundkar, S. H., & Tamimi, Y. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0032 · Cited by 14
The Diet as a Modulator of Tumor Microenvironment in Colorectal Cancer Patients
Collado, M., Castillo, M., de Mier, G. M., de la Pinta, C., & Peña, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087317 · Cited by 12
Glyoxalase System in Breast and Ovarian Cancers: Role of MEK/ERK/SMAD1 Pathway
Alhujaily, M. M. (2024) · Biomolecules · doi:10.3390/biom14050584 · Cited by 12
Biochemical hallmarks-targeting antineoplastic nanotherapeutics
Han, J. G., Dong, H., Zhu, T., Wei, Q., Wang, Y., Wang, Y., Lv, Y. B., Mu, H., Huang, S., Zeng, K., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.042 · Cited by 26
Therapeutic drugs and drug delivery systems targeting stromal cells for cancer therapy: a review
Li, Z., Zheng, Z., Li, C., Li, Z., Wu, J., & Zhang, B. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1744157 · Cited by 12
LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis
Wang, Y., Gong, H., & Cao, Y. (2023) · Hereditas · doi:10.1186/s41065-023-00290-z · Cited by 12
Ji, X., Chen, X., Li, K., Zhang, Z., Tang, L., Li, T., Han, F., Hong, H., & Zhang, T. (2023) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00093 · Cited by 12
Comparative transcriptome of normal and cancer-associated fibroblasts
Abikar, A., Mustafa, M., Athalye, R. R., Nadig, N., Tamboli, N., Babu, V., Keshavamurthy, R., & Ranganathan, P. (2024) · BMC Cancer · doi:10.1186/s12885-024-13006-x · Cited by 11
Rahmati, S., & Emili, A. (2025) · Cancers · doi:10.3390/cancers17020179 · Cited by 12
Past, present, and future of exosomes research in cancer: A bibliometric and visualization analysis
Xie, Y., Mi, X., Xing, Y., Dai, Z., & Pu, Q. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2488551 · Cited by 11
Role of the tumor microenvironment in chemotherapy resistance in ovarian cancer and targeted therapy
Qi, R., Yang, J., Shen, S., Yu, Y., & Yang, Q. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01927-5 · Cited by 12
Challenges and solutions to the study of rare childhood tumors
Fair, D. B., Potter, S. L. P., & Venkatramani, R. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000857 · Cited by 12
Liquid biopsies in myeloid malignancies
Abdulmawjood, B., Roma‐Rodrigues, C., Fernandes, A. R., & Baptista, P. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.88 · Cited by 20
Self-citationImpact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer
Oczko‐Wojciechowska, M., Pfeifer, A., Jarząb, M., Świerniak, M., Rusinek, D., Tyszkiewicz, T., Kowalska, M., Chmielik, E., Zembala‐Nożyńska, E., Czarniecka, A., et al. (2020) · Pathobiology · doi:10.1159/000507223 · Cited by 11
Li, J., Zhang, C., Zhang, C., & Wang, H. (2020) · Aging · doi:10.18632/aging.103251 · Cited by 11
Szczygieł, A., Anger, N., Węgierek‐Ciura, K., Mierzejewska, J., Rossowska, J., Goszczyński, T. M., Świtalska, M., & Pajtasz‐Piasecka, E. (2021) · Oncology Reports · doi:10.3892/or.2021.7930 · Cited by 11
Lachota, M., Lennikov, A., Malmberg, K., & Zagożdżon, R. (2021) · Journal of Immunology Research · doi:10.1155/2021/9920234 · Cited by 13
Sex-Based Differences in the Tumor Microenvironment
Wuidar, V., Gillot, L., Silva, I. D. D., Lebeau, A., Gallez, A., & Péqueux, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_23 · Cited by 11
Wu, Y., Jia, H., Zhou, H., Liu, X., Sun, J., Zhou, X., & Zhao, H. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13119 · Cited by 11
Immuno-onco-metabolism and Therapeutic Resistance
Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11
Wang, H., & Zheng, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-17898-2 · Cited by 12
Wang, Z., Deng, M., Su, J., Liu, D., & Zhou, Y. (2022) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12623 · Cited by 14
Zhang, H., Cao, H., Luo, H., Zhang, N., Wang, Z., Dai, Z., Wu, W., Liu, G., Xie, Z., Cheng, Q., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1086280 · Cited by 13
Zhang, M., Zhu, J., Zhang, P., Li, L., Min, M., Li, T., & He, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1174252 · Cited by 14
Nanomaterials for brain metastasis
Zhao, Z., Chen, Y., Sun, T., & Jiang, C. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.001 · Cited by 12
Xu, X., Cheng, L., Fan, Y., & Mao, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.544789 · Cited by 14
Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes
Nie, X., Song, L., Li, X., Wang, Y., & Qu, B. (2021) · Medicine · doi:10.1097/md.0000000000026574 · Cited by 12
Immunometabolism Modulation in Therapy
Monferrer, E., Sanegre, S., Vieco-Martí, I., López-Carrasco, A., Fariñas, F., Villatoro, A. J., Abanades, S., Mañes, S., de la Cruz‐Merino, L., Noguera, R., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9070798 · Cited by 13
Yang, C., Feng, H., & Dai, C. (2022) · Cancer Medicine · doi:10.1002/cam4.4556 · Cited by 11
Gu, X., Jiang, C., Zhao, J., Qiao, Q., Wu, M., & Cai, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.883059 · Cited by 13
Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
Mbugua, S. N., Njenga, L. W., Odhiambo, R. A., Wandiga, S. O., & Onani, M. O. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200819160213 · Cited by 14
Zhang, C., Ding, J., Xu, X., Liu, Y., Huang, W., Da, L., Ma, Q., & Chen, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.645024 · Cited by 12
Initial Clinical Experience using 68Ga-FAPI-46 PET/CT for Detecting Various Cancer TypesPreprint
Dadgar, H., Norouzbeigi, N., Assadi, M., Albalooshi, B., Al‐Ibraheem, A., Haidar, M., Omar, Y., Esmail, A. A. H., Al-Alawi, H. M., Usmani, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3395633/v1 · Cited by 13
Zhao, X., Xia, X., Wang, X., Bai, M., Zhan, D., & Shu, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.847706 · Cited by 10
Zhou, Y., Qiu, C., Fu, Q., Li, T., Zhang, X., Zhu, C., Qin, X., & Wu, B. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s426558 · Cited by 12
Souza, V. G. P., Telkar, N., Lam, W. L., & Reis, P. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073779 · Cited by 13
Taeb, S., Rostamzadeh, D., Amini, S. M., Rahmati, M. M., Golshekan, M., Abedinzade, M., Ahmadi, E., Singh, N. C., & Najafi, M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266299112240514103048 · Cited by 11
Zhang, Q., Wang, C., Qin, M., Ye, Y., Mo, Y., Meng, Q., Guanglin, Y., Feng, G., Lin, R., Xian, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1298087 · Cited by 17
Organometallic Chemistry Tools for Building Biologically Relevant Nanoscale Systems
Tilden, J. A. R., Doud, E. A., Montgomery, H. R., Maynard, H. D., & Spokoyny, A. M. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c07110 · Cited by 12
Targeting the lung tumor microenvironment by phytochemicals and their nanoformulations
Rab, S. O., Altalbawy, F. M. A., Chandra, M., Ariffin, I. A., Kaur, P., Rathore, G., Rizaev, J. A., Aloraibi, F., Najeeb, M. A., Abdulhussain, M. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155679 · Cited by 12
Application of engineered exosomes in tumor therapy
Ma, C., Tang, W., Wang, J., Yang, S., Hou, J. L., Guo, M., & Lü, H. (2025) · American Journal of Translational Research · doi:10.62347/kixf4662 · Cited by 11
Jiang, M., Zhang, R., Huang, M., Yang, J. B., Liu, Q., Zhao, Z., Ma, Y., Zhao, H., & Zhang, M. (2025) · Cancer Medicine · doi:10.1002/cam4.70614 · Cited by 10
Tumor Microenvironment: An Emerging Landscape for Lung Cancer Therapy
Sohag, S. M., Toma, S. N., Imon, M. A.-I., Maihemuti, M., Ahmed, F., Mimi, M. A., Mahmud, I., & Hasan, M. M. (2025) · Future Pharmacology · doi:10.3390/futurepharmacol5030034 · Cited by 11
Lu, Y., Li, A., Liu, A., Li, M., & Wang, M. (2026) · Biomedicines · doi:10.3390/biomedicines14020416 · Cited by 14
Frostegård, E., Bobrova, T., Leinebø, A., Leray, T., Ghosh, S., García‐Hevia, L., Puccinelli, C., Riccio, L., Sorani, J., Bonifazi, D., et al. (2026) · Advanced Science · doi:10.1002/advs.202522864 · Cited by 12
Nothing to sneeze at: Histamine and histamine receptors in oral carcinogenesis
Salem, A., & Salo, T. A. (2020) · Oral Diseases · doi:10.1111/odi.13411 · Cited by 10
Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment?
Crestani, A., Benoit, L., Touboul, C., & Pasquier, J. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.07.017 · Cited by 10
Sliker, B. H., & Campbell, P. M. (2021) · Vaccines · doi:10.3390/vaccines9060634 · Cited by 13
Targeting Microenvironment of Melanoma and Head and Neck Cancers in Photodynamic Therapy
Ratkaj, I., Mušković, M., & Malatesti, N. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210709113032 · Cited by 10
Cousin, R., Groult, H., Manseur, C., Ferru-Clément, R., Gani, M., Havret, R., Toucheteau, C., Prunier, G., Colin, B., Morel, F., et al. (2021) · Marine Drugs · doi:10.3390/md19100546 · Cited by 10
Xu, H., Cheng, C., & Le, W. (2022) · Electrophoresis · doi:10.1002/elps.202100360 · Cited by 10
Sencha, L. M., Dobrynina, O. E., Pospelov, A. D., Guryev, E. L., Peskova, N. N., Brilkina, A. A., Cherkasova, E. I., & Balalaeva, I. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168837 · Cited by 10
Santana-Krímskaya, S. E., Kawas, J. R., Zárate-Triviño, D. G., Ramos-Zayas, Y., Rodríguez-Padilla, C., & Franco-Molina, M. Á. (2022) · Research in Veterinary Science · doi:10.1016/j.rvsc.2022.08.026 · Cited by 10
Huang, R., Wang, X., Yin, X., Zhou, Y., Sun, J., Yin, Z., & Zhu, Z. H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.976990 · Cited by 10
Shi, H. R., Li, J., Liu, F., Bi, S., Huang, W., Luo, Y., Zhang, M., Song, L., Yu, R., & Zhu, J. (2022) · Food & Function · doi:10.1039/d2fo03483b · Cited by 10
Synthesis and Biological Evaluation of Potential Oncoimmunomodulator Agents
Gil-Edo, R., Espejo, S., Falomir, E., & Cardá, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032614 · Cited by 10
Laforêts, F., Kotantaki, P., Malacrida, B., Elorbany, S., Manchanda, R., Donnadieu, E., & Balkwill, F. R. (2023) · iScience · doi:10.1016/j.isci.2023.106514 · Cited by 11
Wen, H., Ji, T., Lin, L., Cheng, N., Zhu, K., & Cao, L. (2023) · Mediators of Inflammation · doi:10.1155/2023/2664370 · Cited by 12
Role of fibrilins in human cancer: A narrative review
Mahdizadehi, M., Jazi, M. S., Mir, S. M., & Jafari, S. M. (2023) · Health Science Reports · doi:10.1002/hsr2.1434 · Cited by 10
Mokoala, K. M. G., Lawal, I. O., Maserumule, L. C., Bida, M., Maes, A., Ndlovu, H., Reed, J., Mahapane, J., Davis, C., de Wiele, C. V., et al. (2023) · Cancers · doi:10.3390/cancers15153953 · Cited by 11
Ding, B., Zheng, P., Tan, J., Chen, H., Meng, Q., Li, J., Li, X., Han, D., Li, Z., Ma, X., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202307706 · Cited by 10
Fabrication Method of a High-Density Co-Culture Tumor–Stroma Platform to Study Cancer Progression
Saini, H., & Nikkhah, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1174-6_16 · Cited by 10
Characterizing Immune Responses in Whole Slide Images of Cancer With Digital Pathology and Pathomics
Gupta, R., Le, H., Arnam, J. V., Belinsky, D., Hasan, M., Samaras, D., Kurç, T., & Saltz, J. H. (2020) · Current Pathobiology Reports · doi:10.1007/s40139-020-00217-7 · Cited by 10
Zhao, J., Huang, S., Tan, D., Yang, K., Chen, M., Jia, X., & Mao, X. (2022) · Journal of Oncology · doi:10.1155/2022/8581805 · Cited by 14
Xie, S., Ding, B., Wang, S., Zhang, X., Yan, W., Xia, Q., Meng, D., Shen, S., Yu, B., Liu, H., et al. (2022) · International Immunology · doi:10.1093/intimm/dxac017 · Cited by 12
Chen, Y., Yuan, X., Pei, C., Deng, Z., Du, X., Liang, J., He, L., & Hou, S. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105190 · Cited by 10
Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer
Kääriäinen, A., Pesola, V., Dittmann, A., Kontio, J., Koivunen, J. T., Pihlajaniemi, T. A., & Izzi, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228837 · Cited by 10
Wu, F., Xu, J., Jin, M., Jiang, X., Li, J., Li, X., Chen, Z., Nie, J., Meng, Z., & Wang, G. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.705148 · Cited by 10
Tieng, F. Y. F., Lee, L., & Mutalib, N. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959705 · Cited by 11
Tornaas, S., Kleftogiannis, D., Fromreide, S., Smeland, H. Y., Aarstad, H. J., Vintermyr, O. K., Akslen, L. A., Costea, D. E., & Dongre, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31191 · Cited by 11
Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models
Neitzel, L. R., Fuller, D. T., Williams, C. H., & Hong, C. C. (2024) · BMC Research Notes · doi:10.1186/s13104-024-06900-x · Cited by 13
Dai, Q., Peng, Y., He, P., & Wu, X. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2418344 · Cited by 9
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects
Tang, L., Chen, X., Hou, J., & Wei, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06022-9 · Cited by 10
Research progress on the mechanism and treatment of cachexia based on tumor microenvironment
Zhao, B., Shi, G., Shi, J., Li, Z., Xiao, Y., Qiu, Y., He, L., Xie, F., Yu, D. N., Cao, H., et al. (2025) · Nutrition · doi:10.1016/j.nut.2025.112697 · Cited by 10
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
suri, C., Pande, B., Sahithi, L. S., Swarnkar, S., Khelkar, T., & Verma, H. K. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.164 · Cited by 14
Wang, T., Song, W., Tang, Y., Yi, J., & Pan, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189353 · Cited by 11
Carbon dot-based nanohybrids for tumor microenvironment-activated cancer theranostics
Girma, W. M., Mekuria, S. L., Gedda, G., Shi, X., Park, Y.-J., & Pang, M. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217236 · Cited by 15
Barua, R., Das, D., & Biswas, N. (2025) · Biomicrofluidics · doi:10.1063/5.0268362 · Cited by 10
CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent
Ramalingam, P. S., Afzal, M., Babu, M. A., Rekha, M. M., Sahoo, S., Pandey, S. N., Goyal, K., Hussain, M. S., Gupta, G., Balakrishnan, P., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1683585 · Cited by 9
Pavlatovská, B., Machálková, M., Brisudová, P., Pruška, A., Štěpka, K., Michálek, J., Nečasová, T., Beneš, P., Šmarda, J., Preisler, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581365 · Cited by 9
Kan, A., Wang, S., Zhang, L., Xu, X., Zhang, N., & Jiang, W. (2021) · Talanta · doi:10.1016/j.talanta.2021.122284 · Cited by 9
Moisejenko-Goluboviča, J., Volkov, O., Ivanova, A., & Groma, V. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.20 · Cited by 9
Pharmacokinetics and in vivo evaluation of nanoparticles
Biswas, L., Mahtab, A., & Verma, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820757-4.00006-5 · Cited by 11
Cai, L., Ying, M., & Wu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.777273 · Cited by 14
Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer
Zhang, K., Wang, J., Xu, C., Zhang, J., Li, H., Zhou, X., Zhao, X., Peng, S., Jiang, Y., Yang, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06334-0 · Cited by 10
Mostafa, N., Salem, A. M. H., Mansour, S. Z., El-Sonbaty, S. M., Moawed, F. S., & Kandil, E. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221085376 · Cited by 9
Cabeza-Segura, M., Gambardella, V., Gimeno-Valiente, F., Carbonell‐Asins, J. A., Alarcón‐Molero, L., González-Vilanova, A., Zúñiga, S., Rentero-Garrido, P., Villagrasa, R., Gil-Raga, M., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02005-z · Cited by 11
Chen, J., Wang, G., Zhang, D., Luo, X., Zhang, D., & Zhang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075431 · Cited by 9
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.